IP and R&D Spark Newsletter

This month’s Legal Watch features decisive rulings and rising tensions in the patent law sphere. The Federal Circuit draws a sharper line on Article III standing, requiring clear injury for appeals in post-grant reviews. A copyright clash erupts as Disney and Universal battle over AI-generated content, blending blockbuster media with precedent-setting IP questions. Courts take aim at drug-device patent strategies in light of FDA Orange Book complexities, while Judge Stark’s dissent in a tile-levelling case reignites debates over overly narrow claim constructions.

In Industry News, the USPTO’s transparency review of large patent families prompts global conversation on strategic filing behavior. The U.S. reasserts support for injunction rights in cross-border disputes, and India opens public consultation to revamp CRI patent guidelines. Australia champions genetic equity by backing the WIPO treaty on traditional knowledge, while the EPO advances clarity in claim interpretation through Decision G 1/24. A renewed EPO–South Korea partnership signals deeper cooperation in AI governance and global IP frameworks. This month’s Techno Spotlight showcases breakthroughs redefining sustainability, healthcare, and high-tech systems. A biodegradable battery inspired by Mission: Impossible takes center stage, alongside okra- and fungi-based solutions for microplastics and green metal recovery. Researchers transform carbon waste into cement precursors, while CRISPR and microbiome therapies reshape the future of metabolic and rare disease care. UBC’s universal translator chip pushes the frontier of real-time communication, and robotic skin brings human-like touch to machines. Xiaomi stakes ground with a solid-state EV battery patent, aerospace innovators unveil drone-optimized jet engines, and SEP licensing disputes escalate across Europe amid calls for regulatory clarity.

Stay tuned for more innovation shaping the IP and R&D landscape!